TLSA logo

TLSA

Profile

Full Name

Tiziana Life Sciences Ltd

Ticker Symbol

TLSA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United Kingdom

IPO

November 20, 2018

Indexes

Not included

Website

http://www.tizianalifesciences.com

Employees

9

Key Details

Price

$0.79(+1.28%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.17(-13.33% YoY)

PE ratio

-

Next earnings date

Oct 17, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.79
TLSA price is $0.79

30-Day Relative Volume

0.37
TLSA 30-day relative volume is 0.37

Price Performance

Price Most recent change

+1.28%
TLSA price was up +1.28% on Apr 11, 2025

Price YTD change

+12.86%
TLSA price is up +12.86% since January 1st

Price 1-year change

+79.55%
TLSA price is up +79.55% year-on-year

Price 3-year change

-16.84%
TLSA price is down -16.84% over the past 3 years

Price Range

Price All-time high

$12.17
TLSA price is currently -93.51% below its historical high of $12.17

Price 3-year low

$0.41
TLSA price is currently +92.68% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$92.31M
TLSA market capitalization is $92.31 million

Market cap 3-year change

-4.99%
TLSA market capitalization is down -4.99% over the past 3 years

Market cap All-time high

$589.05M
TLSA market capitalization is currently -84.33% below its historical high of $589.05 million

Market cap sector rank

48.23%
TLSA market capitalization is higher than 48.23% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+15.1%
TLSA shares outstanding is up +15.1% year-on-year

Shares Outstanding 3-Year Change

+14.25%
TLSA shares outstanding is up +14.25% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.87
TLSA beta is 0.87

200-day SMA

$0.97
TLSA price is currently -18.36% below its 200-day simple moving average

50-day SMA

$1.05
TLSA price is currently -25.02% below its 50-day simple moving average

RSI

35.47
TLSA 14-day relative strength index is 35.47

Volume

0.37
TLSA 30-day relative volume is 0.37

ATR

$0.13
TLSA average true range is $0.13

10-day Historical Volatility

98.39%
TLSA 10-day historical volatility is 98.39%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
TLSA annual revenue value is unknown

Revenue Analysts estimate

-
TLSA annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
TLSA annual revenue 1-year change is unknown

Revenue Sector rank

-
TLSA annual revenue is unknown

EPS

EPS

-$0.17
TLSA annual earnings per share is -$0.17

EPS Analysts estimate

-
TLSA annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-13.33%
TLSA annual earnings per share is down -13.33% year-on-year

EPS Sector rank

78.61%
TLSA annual earnings per share is higher than 78.61% of companies in Healthcare sector

Profit

Gross profit

-
TLSA annual gross profit value is unknown

Gross margin

-
TLSA annual gross profit margin value is unknown

Operating profit

-$17.98M
TLSA annual operating income is -$17.98 million

Operating margin

-
TLSA annual operating profit margin value is unknown

Net income

-$17.69M
TLSA annual net profit is -$17.69 million

Net margin

-
TLSA annual net profit margin value is unknown

Expenses

Total expenses

$17.98M
TLSA annual total expenses is $17.98 million

Operating expenses

$17.98M
TLSA annual total operating expenses is $17.98 million

Cost of goods sold

-
TLSA annual cost of goods sold value is unknown

Selling, general & administrative expenses

$0.00
TLSA annual SGA is $0.00

Depreciation and amortization

$96.00K
TLSA annual depreciation & amortization is $96.00 thousand

Interest expense

$10.00K
TLSA annual interest expense is $10.00 thousand

Income tax

$449.00K
TLSA annual income tax is $449.00 thousand

EBIT & EBITDA

EBIT

-$17.23M
TLSA annual earnings before interest & taxes is -$17.23 million

EBITDA

-$17.14M
TLSA annual EBITDA is -$17.14 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$12.18M
TLSA annual total assets is $12.18 million

Non current assets

$4.85M
TLSA annual long term assets is $4.85 million

Current assets

$7.34M
TLSA annual total current assets is $7.34 million

Cash and cash equivalents

$1.18M
TLSA annual cash & cash equivalents is $1.18 million

Accounts receivable

-
TLSA annual accounts receivable value is unknown

Inventory

-
TLSA annual inventory value is unknown

Liabilities

Total liabilities

$6.65M
TLSA annual total liabilities is $6.65 million

Long term liabilities

$109.00K
TLSA annual total long term liabilities is $109.00 thousand

Current liabilities

$6.54M
TLSA annual total current liabilities is $6.54 million

Accounts payable

$4.14M
TLSA annual accounts payable is $4.14 million

Debt

Total debt

$247.00K
TLSA annual total debt is $247.00 thousand

Total debt 1-year change

-32.33%
TLSA annual total debt is down -32.33% year-on-year

Long term debt

$109.00K
TLSA annual long term debt is $109.00 thousand

Short term debt

$138.00K
TLSA annual short term debt is $138.00 thousand

Equity & Capital

Shareholders equity

$5.54M
TLSA annual stockholders equity is $5.54 million

Book value

$5.54M
TLSA annual book value is $5.54 million

Retained earnings

-$133.68M
TLSA annual retained earnings is -$133.68 million

Working capital

$798.00K
TLSA annual working capital is $798.00 thousand

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$15.70M
TLSA annual cash flow from operations is -$15.70 million

Cash from operations 1-year change

+19.97%
TLSA annual cash flow from operations is up +19.97% year-on-year

Cash from investing

-$1.25M
TLSA annual cash flow from investing activities is -$1.25 million

Cash from investing 1-year change

+68.64%
TLSA annual cash flow from investing activities is up +68.64% year-on-year

Cash from financing

$40.00K
TLSA annual cash flow from financing activities is $40.00 thousand

Cash from financing 1-year change

+172.73%
TLSA annual cash flow from financing activities is up +172.73% year-on-year

CAPEX

CAPEX

-
TLSA annual capital expenditures value is unknown

CAPEX 1-year change

-
TLSA annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$15.70M
TLSA annual free cash flow is -$15.70 million

Free cash flow 1-year change

+19.97%
TLSA annual free cash flow is up +19.97% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
TLSA annual gross profit margin value is unknown

Operating margin

-
TLSA annual operating profit margin value is unknown

Net margin

-
TLSA annual net profit margin value is unknown

ROA & ROE

ROA

-145.20%
TLSA annual return on assets is -145.20%

ROE

-319.56%
TLSA annual return on equity is -319.56%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
TLSA price to earnings ratio value is unknown

PE ratio Sector rank

-
TLSA price to earnings ratio is unknown

PB Ratio

PB ratio

49.76
TLSA price to book ratio is 49.76

PB ratio Sector rank

98.77%
TLSA price to book ratio is higher than 98.77% of companies in Healthcare sector

PS Ratio

PS ratio

-
TLSA price to sales ratio value is unknown

PS ratio Sector rank

-
TLSA price to sales ratio is unknown

Enterprise value

Enterprise value

$91.36M
TLSA enterprise value is $91.36 million

Enterprise value Sector rank

49.55%
TLSA enterprise value is higher than 49.55% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
TLSA EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
TLSA EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.12
TLSA annual current ratio is 1.12

Quick ratio

-
TLSA annual quick ratio value is unknown

Leverage

Debt to equity

0.04
TLSA annual debt to equity ratio is 0.04

Interest coverage ratio

-1723.20
TLSA annual interest coverage ratio is -1723.20

Risk & Stability

Piotroski F-Score

-
TLSA piotroski f-score value is unknown

Altman Z-Score

-
TLSA altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Sep 6, 22 ThinkEquity
Buy
Jun 13, 22 ThinkEquity
Buy
Apr 12, 21 Zacks Investment Research
Not Rated
Sep 21, 20 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

Genelux (GNLX)
OPTN logo
OptiNose (OPTN)
eXoZymes (EXOZ)
ALEC logo
Alector (ALEC)
PROK logo
ProKidney (PROK)
THTX logo
Theratechnologies (THTX)
KYTX logo
Kyverna Therapeutics (KYTX)
MGRM logo
Monogram Orthopaedics (MGRM)
Anteris Technologies Global (AVR)
  • What is the ticker symbol for Tiziana Life Sciences Ltd?
  • Does Tiziana Life Sciences Ltd pay dividends?
  • What sector is Tiziana Life Sciences Ltd in?
  • What industry is Tiziana Life Sciences Ltd in?
  • What country is Tiziana Life Sciences Ltd based in?
  • When did Tiziana Life Sciences Ltd go public?
  • Is Tiziana Life Sciences Ltd in the S&P 500?
  • Is Tiziana Life Sciences Ltd in the NASDAQ 100?
  • Is Tiziana Life Sciences Ltd in the Dow Jones?
  • When was Tiziana Life Sciences Ltd's last earnings report?
  • When does Tiziana Life Sciences Ltd report earnings?
  • Should I buy Tiziana Life Sciences Ltd stock now?

What is the ticker symbol for Tiziana Life Sciences Ltd?

The ticker symbol for Tiziana Life Sciences Ltd is NASDAQ:TLSA

Does Tiziana Life Sciences Ltd pay dividends?

No, Tiziana Life Sciences Ltd does not pay dividends

What sector is Tiziana Life Sciences Ltd in?

Tiziana Life Sciences Ltd is in the Healthcare sector

What industry is Tiziana Life Sciences Ltd in?

Tiziana Life Sciences Ltd is in the Biotechnology industry

What country is Tiziana Life Sciences Ltd based in?

Tiziana Life Sciences Ltd is headquartered in United Kingdom

When did Tiziana Life Sciences Ltd go public?

Tiziana Life Sciences Ltd's initial public offering (IPO) was on November 20, 2018

Is Tiziana Life Sciences Ltd in the S&P 500?

No, Tiziana Life Sciences Ltd is not included in the S&P 500 index

Is Tiziana Life Sciences Ltd in the NASDAQ 100?

No, Tiziana Life Sciences Ltd is not included in the NASDAQ 100 index

Is Tiziana Life Sciences Ltd in the Dow Jones?

No, Tiziana Life Sciences Ltd is not included in the Dow Jones index

When was Tiziana Life Sciences Ltd's last earnings report?

Tiziana Life Sciences Ltd's most recent earnings report was on Oct 18, 2024

When does Tiziana Life Sciences Ltd report earnings?

The next expected earnings date for Tiziana Life Sciences Ltd is Oct 17, 2025

Should I buy Tiziana Life Sciences Ltd stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page